Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Westlake Village, CA, US. The stock last traded at $12.49, down 5.81% on the session, giving a market capitalisation of $372.1M. On trailing twelve-month figures it carries a trailing P/E of -42.86, a net margin of 0.0%. Its beta of 2.05 implies it has historically moved more than the broad market.
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
Turn Therapeutics Inc. is most often compared with the following Healthcare names: